Literature DB >> 33851977

Analysis of Price Transparency for Oncologic Surgery Among National Cancer Institute-Designated Cancer Centers in 2020.

Roy Xiao1,2, Lauren E Miller1,2, Alan D Workman1,2, Ryan A Bartholomew1,2, Lucy J Xu1,2, Vinay K Rathi1,2.   

Abstract

Entities:  

Year:  2021        PMID： 33851977      PMCID： PMC8047718          DOI： 10.1001/jamasurg.2021.0590

Source DB:  PubMed          Journal:  JAMA Surg        ISSN： 2168-6254            Impact factor:   14.766


× No keyword cloud information.
  4 in total

1.  Accessibility and Usability of Hospital Chargemasters in New York State.

Authors:  Sonika Reddy; Gwendolyn Daly; Saman Baban; Amanda Kadesh; Adam E Block; Cara L Grimes
Journal:  J Gen Intern Med       Date:  2021-10-28       Impact factor: 6.473

2.  Payer-Negotiated Prices in the Diagnosis and Management of Thyroid Cancer in 2021.

Authors:  Roy Xiao; Vinay K Rathi; Cary P Gross; Joseph S Ross; Rosh K V Sethi
Journal:  JAMA       Date:  2021-06-04       Impact factor: 56.272

3.  Cost Comparison From a Patient Perspective for Intracranial Stereotactic Radiation Therapy.

Authors:  Rahul N Prasad; Vedat O Yildiz; Tejash Patel; Trevor J Royce; Joshua D Palmer
Journal:  Adv Radiat Oncol       Date:  2021-10-26

4.  Correlates of Price Transparency for Healthcare Services in United States Hospitals.

Authors:  David N Younessi; John C Lin; Paul B Greenberg; Dustin D French
Journal:  Clinicoecon Outcomes Res       Date:  2022-09-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.